Gm5935, a predicted gene involved in the meiotic cell cycle and spermatid development, plays a crucial role within the synaptonemal complex. This complex, fundamental to meiosis, is responsible for pairing and recombination of homologous chromosomes, ensuring the faithful transmission of genetic information. Predicted to be active in the synaptonemal complex, Gm5935 likely contributes to the regulation of these intricate processes, emphasizing its significance in the highly orchestrated events of meiosis. In the context of spermatid development, Gm5935's involvement implies a critical role in the transformation of haploid round spermatids into elongated, mature spermatozoa. This intricate cellular process requires precise coordination, and disruptions to Gm5935 could potentially lead to aberrations in meiotic progression, impacting the formation of functional sperm. The orthology of Gm5935 to human SYCP3 further underscores its evolutionary conservation and hints at shared molecular mechanisms governing meiotic events across species.
Inhibiting Gm5935 involves targeting key cellular pathways associated with meiotic cell cycle progression and spermatid development. For instance, compounds affecting the cell cycle, such as those inhibiting cyclin-dependent kinases (CDKs), may disrupt the orchestrated events of meiosis. Additionally, inhibitors influencing DNA repair processes, such as PARP inhibitors, could compromise the integrity of DNA during meiotic events, potentially interfering with Gm5935 function. Alterations in chromatin structure, achieved through histone deacetylase (HDAC) inhibitors, may impact the epigenetic landscape and, consequently, Gm5935 expression. Similarly, microtubule-stabilizing agents and topoisomerase inhibitors could disturb essential processes during meiosis, potentially influencing Gm5935's role within the synaptonemal complex. The identified inhibitors collectively provide a toolset to dissect the intricate molecular mechanisms governing Gm5935's function, shedding light on its contribution to meiotic cell cycle regulation and spermatid development.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
A non-selective inhibitor of CDKs, including CDK4/6. Modulates the cell cycle and may impact meiotic progression, potentially influencing Gm5935 function in spermatid development. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor influencing histone acetylation patterns. Alters chromatin structure, potentially impacting Gm5935 expression and function during spermatid development. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A microtubule-stabilizing agent that interferes with mitotic spindle dynamics. Disruption of microtubule function may indirectly affect Gm5935 and its role in spermatid development. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
A PARP inhibitor that impairs DNA repair processes. Indirectly influences Gm5935 by affecting DNA integrity during meiotic cell cycle progression and spermatid development. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor altering histone acetylation. Modulates chromatin structure, potentially influencing Gm5935 expression and function during spermatid development. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
A CHK1/2 inhibitor impacting cell cycle checkpoints. Modulation of CHK activity may indirectly influence Gm5935 during meiotic events and spermatid development. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
A topoisomerase I inhibitor affecting DNA topology. Disruption of DNA structure may impact meiotic cell cycle progression, indirectly influencing Gm5935 and spermatid development. | ||||||
Ceralasertib | 1352226-88-0 | sc-507439 | 10 mg | $573.00 | ||
An ATR kinase inhibitor involved in DNA damage response. Inhibition may disrupt the meiotic cell cycle, indirectly affecting Gm5935 and its role in spermatid development. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
A PLK1 inhibitor influencing cell cycle progression. Modulation of Polo-like kinase 1 may indirectly impact Gm5935 during meiosis and spermatid development. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNMT inhibitor affecting DNA methylation. Alters epigenetic regulation, potentially influencing Gm5935 expression and function during spermatid development. | ||||||